Cargando…
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
BACKGROUND: The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. There are no specific guidelines for their management. METHODS: The clinical records of elderly patients (⩾70 years old) with MPM referred from January 2005 to November 2011 to six Italian Centres we...
Autores principales: | Ceresoli, G L, Grosso, F, Zucali, P A, Mencoboni, M, Pasello, G, Ripa, C, Degiovanni, D, Simonelli, M, Bruzzone, A, Dipietrantonj, C, Piccolini, E, Beretta, G D, Favaretto, A G, Giordano, L, Santoro, A, Botta, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102949/ https://www.ncbi.nlm.nih.gov/pubmed/24918816 http://dx.doi.org/10.1038/bjc.2014.312 |
Ejemplares similares
-
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
por: Ceresoli, G L, et al.
Publicado: (2013) -
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
por: Ceresoli, G L, et al.
Publicado: (2008) -
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma
por: Canova, S., et al.
Publicado: (2022) -
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data
por: Pasello, Giulia, et al.
Publicado: (2015) -
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
por: Pagano, Maria, et al.
Publicado: (2020)